11-36401152-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001160167.2(PRR5L):c.31G>T(p.Val11Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000075 in 1,614,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001160167.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRR5L | NM_001160167.2 | c.31G>T | p.Val11Phe | missense_variant | 2/9 | ENST00000530639.6 | NP_001153639.1 | |
PRR5L | NM_024841.5 | c.31G>T | p.Val11Phe | missense_variant | 3/10 | NP_079117.3 | ||
PRR5L | NM_001160169.1 | c.31G>T | p.Val11Phe | missense_variant | 1/7 | NP_001153641.1 | ||
PRR5L | NM_001160168.2 | c.3-18103G>T | intron_variant | NP_001153640.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRR5L | ENST00000530639.6 | c.31G>T | p.Val11Phe | missense_variant | 2/9 | 2 | NM_001160167.2 | ENSP00000435050.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251054Hom.: 0 AF XY: 0.000214 AC XY: 29AN XY: 135670
GnomAD4 exome AF: 0.0000794 AC: 116AN: 1461846Hom.: 0 Cov.: 30 AF XY: 0.000121 AC XY: 88AN XY: 727218
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | The c.31G>T (p.V11F) alteration is located in exon 2 (coding exon 1) of the PRR5L gene. This alteration results from a G to T substitution at nucleotide position 31, causing the valine (V) at amino acid position 11 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at